Scimplify, an India-based startup specializing in connecting pharmaceutical and agriculture companies with specialty chemical suppliers, has secured $40 million in a Series B funding round. The investment, co-led by Accel and Bertelsmann Investments, values the company at approximately $150 million post-money. The fresh capital will support Scimplify’s expansion into the U.S. and other global markets.
Specialty chemicals are essential in industries such as pharmaceuticals, agriculture, and manufacturing. However, sourcing these chemicals remains a challenge as manufacturers are scattered worldwide. Historically, companies have relied on Chinese suppliers, but rising geopolitical tensions are driving the need for diversified sourcing options. Additionally, businesses often struggle to find specific chemicals that meet regulatory standards, such as U.S. FDA or GMP compliance.
Scimplify bridges this gap through its proprietary platform, ATOMS, which features a catalog of specialty chemicals sourced from over 5,000 factories operated by more than 200 manufacturers across 10 countries, including India, China, Vietnam, Egypt, and Japan. The platform simplifies procurement, ensuring manufacturers can access the exact chemicals they need.
How Scimplify Stands Out
Unlike traditional marketplaces, Scimplify goes beyond listing chemicals. The startup vets manufacturers, conducts third-party audits twice a year, and categorizes suppliers based on geography, chemistry, capacity, and compliance. Additionally, Scimplify optimizes existing chemicals to enhance cost-effectiveness and adapt them for various industry applications.
Since its inception in 2023, Scimplify has served over 600 customers across 16 countries. The company also offers made-to-order chemical solutions, allowing businesses to transition seamlessly between different chemical formulations within its vast manufacturer network.
Expansion Plans and Future Growth
Scimplify plans to utilize its new funding to expand its geographic footprint, enter new industry segments, and invest in research and development. The company already operates subsidiaries in Dubai and Indonesia and is now eyeing offices in the U.S. and Japan. With a team of 150 employees, Scimplify is also considering acquiring one or two chemical factories to enhance its offerings and enter regulated markets.
The Series B round also saw participation from UMI and returning investors Omnivore and 3one4 Capital. To date, Scimplify has raised $54 million in total funding, positioning itself as a key player in the specialty chemical supply chain.
As global supply chain dynamics shift, Scimplify’s innovative platform and strategic growth initiatives are set to redefine specialty chemical procurement for manufacturers worldwide.
For more funding news, click here.
